Johnson & Johnson (JNJ)
Key Statistics
EV/EBIT = 26.27x
ROE = 18.57%
Debt/Equity = 44%
FCF Yield = 4.8%
Dividend Yield = 3.06%
Market Capitalization = $373.65 billion
The Company
Johnson & Johnson (JNJ) is a healthcare company with 131,900 employees worldwide.
Their focus is on pharmaceutical products and medical devices. The advantages of all of these businesses are that they are frequent, repeat purchases that are necessities. These characteristics give the business remarkable stability of margins and cash flows.
Their pharmaceutical division has top-selling drugs like STELARA (used for the treatment of psoriasis and psoriatic arthritis) and DARZALEX (used for the treatment of multiple myeloma).
The medical device group holds leading positions in various areas, including orthopedic implants and instruments, surgical instruments for minimally invasive procedures, advanced surgical devices for neurosurgery, cardiovascular surgery, and general surgery, contact lenses, diabetes care products, wound care products, respiratory therapy equipment, diagnostic equipment, and interventional products for cardiology and vascular procedures.